Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VIVO Cannabis (LABS)

VIVO Cannabis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:LABS
DateTimeSourceHeadlineSymbolCompany
08/05/202421:30PR Newswire (US)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
08/05/202421:30PR Newswire (Canada)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
27/03/202414:54PR Newswire (Canada)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202414:54PR Newswire (US)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202410:30PR Newswire (US)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
27/03/202410:30PR Newswire (Canada)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
25/03/202410:30PR Newswire (Canada)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
25/03/202410:30PR Newswire (US)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
22/03/202410:30PR Newswire (US)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
22/03/202410:30PR Newswire (Canada)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
07/02/202411:30PR Newswire (US)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
07/02/202411:30PR Newswire (Canada)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
22/12/202312:00PR Newswire (US)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
22/12/202312:00PR Newswire (Canada)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
14/11/202312:15PR Newswire (US)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
14/11/202312:15PR Newswire (Canada)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
08/11/202322:01PR Newswire (US)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
08/11/202322:01PR Newswire (Canada)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
25/10/202312:00PR Newswire (US)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
25/10/202312:00PR Newswire (Canada)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
02/10/202312:00PR Newswire (US)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
02/10/202312:00PR Newswire (Canada)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
27/09/202312:15PR Newswire (Canada)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
27/09/202312:15PR Newswire (US)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
20/09/202312:00PR Newswire (US)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
20/09/202312:00PR Newswire (Canada)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
05/09/202312:39PR Newswire (US)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
05/09/202312:39PR Newswire (Canada)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
31/08/202313:02PR Newswire (US)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
31/08/202313:02PR Newswire (Canada)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
 Showing the most relevant articles for your search:TSX:LABS